Fritextsökning
Innehållstyper
-
Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”
It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...
-
Konstgjord andning – från bibeln till den moderna respiratorn
Det är tidig vår 2021 och portarna till Medicinhistoriska muséet i Uppsala är stängda, utanför pågår en pandemi. Life Science Sweden får komma in och botanisera...
-
Swedish life science in political focus
It feels like 2017 will be a good year for Swedish life science, says Anders Blanck, CEO at LIF.
-
Helena Strigård: The rise of the community
Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.
-
Double the channels for half the work
The 16-well pipettes from Capp cause less strain for the user when setting up a 384-well plate.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
BREAKING